Please check your internet connection and try again.
# Arsil DX (Dextromethorphan/Chlorpheniramine/Phenylephrine)
## Overview
Arsil DX is a fixed-dose combination product containing:
* **Dextromethorphan HBr:** Antitussive (cough suppressant).
* **Chlorpheniramine Maleate:** First-generation antihistamine.
* **Phenylephrine HCl:** Sympathomimetic (nasal decongestant).
## Primary Indications
Temporary relief of upper respiratory symptoms, including cough, sneezing, runny nose, and nasal congestion associated with the common cold or allergic rhinitis.
## Adult Dosing
Standard formulation (typically 10 mg dextromethorphan / 2 mg chlorpheniramine / 5 mg phenylephrine per 5-10 mL):
* **Dosage:** 10 mL every 4 to 6 hours.
* **Maximum:** 40 mL per 24 hours.
## Pediatric Dosing
* **Ages 6 to <12 years:** 5 mL every 4 to 6 hours. Maximum 20 mL per 24 hours.
* **Ages <6 years:** Generally discouraged due to lack of efficacy and safety concerns; consult a pediatrician. Use specific pediatric formulation if directed by a provider.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific manufacturer guidelines, but caution is advised in severe impairment due to drug clearance concerns.
* **Geriatric:** Increased risk of sedation, confusion, and urinary retention with chlorpheniramine. Use the lowest effective dose or avoid if possible (Beers Criteria).
## Contraindications
* Hypersensitivity to any component.
* Concurrent use of MAO inhibitors (or within 14 days of discontinuation).
* Severe hypertension or severe coronary artery disease (due to phenylephrine).
## Adverse Effects
* **Common:** Drowsiness, dizziness, dry mouth/nose/throat.
* **Serious:** Paradoxical excitation (children), urinary retention, elevated blood pressure, tachycardia, and serotonin syndrome (rare, if combined with serotonergic agents).
## Key Drug Interactions
* **MAOIs:** Fatal hypertensive crisis or serotonin syndrome.
* **CNS Depressants (Alcohol, Opioids, Sedatives):** Enhanced sedation.
* **Antihypertensives:** Phenylephrine may antagonize the therapeutic effects.
* **SSRIs/SNRIs:** Increased risk of serotonin syndrome when combined with dextromethorphan.
## Monitoring
* Monitor blood pressure and heart rate in patients with preexisting cardiovascular conditions.
* Assess for excessive sedation or urinary hesitancy.
* Monitor for symptom resolution; discontinue if cough persists >7 days or is accompanied by high fever.
## Clinical Pearls
* **Sedation:** Advise patients regarding drowsiness and the impairment of driving or operating heavy machinery.
* **Combination Safety:** Check for overlapping active ingredients in other OTC products (e.g., Tylenol Cold & Flu) to avoid accidental overdose.
* **Dextromethorphan:** High doses can lead to hallucinogenic effects; monitor for potential abuse.
* **Phenylephrine Efficacy:** Its oral efficacy as a decongestant is frequently debated; ensure local clinical guidelines support its use.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify specific dosing, safety, and contraindications against the current FDA-approved package insert or local institutional protocols before prescribing or administering medication. Consult a physician or pharmacist for clinical decision-making.
